hr. These observations indicate that functional adaptation of renal heme oxygenase activity reflects enzyme induction either directly or indirectly by the substrate, hemoglobin.
Filtered rather than plasma hemoglobin appears to regulate renal heme oxygenase activity. Thus, stabilization of plasma hemoglobin in its tetrameric form with bis (N-maleimidomethyl) ether, which diminishes its glomerular filtration and retards it plasma clearance, results in reduced enzyme stimulation in the kidney, but enhances its activity in the liver. These findings suggest that the enzyme is localized in the tubular epithelial cells rather than in the glomeruli and is activated by luminal hemoglobin. Direct support for this concept was obtained by the demonstration of heme oxygenase activity in renal tubules isolated from rabbits that had been injected with hemoglobin.
INTRODUCTION
Recent studies have defined an enzymatic mechanism by which the heme moiety of hemoglobin is converted to bile pigment (2) (3) (4) . The rate-limiting enzyme is heme oxygenase, which is a microsomal enzyme containing cytochrome P450 as the terminal oxidase (4, 5) . It catalyzes the oxidation of heme at the a-methene bridge (3) to form equimolar amounts of biliverdin and of carbon monoxide (5) . The biliverdin then is reduced to bilirubin by the NADPH-dependent soluble enzyme, biliverdin reductase (6, 7) .
Heme oxygenase is most active in organs normally engaged in the sequestration and breakdown of senescent red cells, namely spleen, liver, and bone marrow (5) . Its activity in rat spleen, as determined in vitro, is in good agreement with the requirements for the normal turnover of erythrocyte-hemoglobin in the intact
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The Journal of Clinical Investigation Volume 50 1971 animals (2) . After splenectomy, or in conditions where the turnover of hemoglobin is accelerated, for instance in hemolytic anemia (4, 5) , hepatic heme oxygenase activity is elevated reflecting the increased amount of hemoglobin that is removed by the liver (8) . Similarly, enzyme activity is enhanced in isolated peritoneal or alveolar macrophages that, in vivo, have ingested hemin or hemoglobin before being harvested (9) . These findings leave little doubt that the activity of heme oxvgenase is controlled by the amount of heme that is offered for catabolism. The nature of this regulatory mechanism is described in the present report, using the response of the kidney to hemoglobinuria as the experimental model. As the kidney normally is not involved in the breakdown of red cells or hemoglobin, it expectedly has very low levels of heme oxygenase activity (5) . However, in severe intravascular hemolysis, when hemoglobin released from circulating red cells exceeds the binding capacity of the plasma haptoglobin (10) , unbound hemoglobin may be filtered by the renal glomeruli and appear in the urine (11) . From the study of Bunn and Jandl (12) , it would appear that in hemoglobinemia with hemoglobinuria, the kidney may be able to catabolize part of the filtered hemoglobin that has been reabsorbed by proximal convoluted tubules (13) (14) (15) (16) . If this were the case, one would expect the kidney to respond to hemoglobinuria with increased heme oxygenase activity and one would further predict that this adaptive mechanism is localized in the tubular epithelial cells. We have investigated this relationship under optimal experimental conditions in rats made hemoglobinuric with intravenous injections of hemoglobin.
METHODS
Most experiments were carried out in female SpragueDawley rats, weighing 250-350 g. The animals had free access to water and to Berkeley Diet Chow (Berkeley Biologicals, Berkeley, Calif.). In studies requiring analysis of urine, rats were housed in metabolic cages permitting uninterrupted and quantitative urine collection.
Rat hemoglobin was obtained as outlined by Bunn, Esham, and Bull (11) . Isotopically labeled rat hemoglobin was prepared by the method of Keene and Jandl (17) using 'FeCl3 (Tracer Lab, Waltham, Mass.) as isotopic precursor. The hemoglobin was complexed with bis (N-maleimidomethyl) ether (BME)' as described by Bunn et al. (11) . Titration of the reactive sulfhydryl groups of hemoglobin solutions treated with BME2 (18) indicated that the reaction had gone to completion. The concentration of hemoglobin in these solutions, measured as cyanmethemoglobin (19) , was usually between 40 and 60 mg per ml. In rat urine, the hemoglobin concentration was measured by the benzidine method (20) . Radioactivity in samples containing 'Fe was measured in a well-type scintillation counter (Nuclear-'Kindly supplied by Uniroyal Inc., Wayne, N. J. 2Abbreviations used in this paper: BME, bis(N-maleimidomethyl) ether.
Chicago Corp., Des Plaines, Ill.) for a minimum of either 10 min or 10,000 counts. For these determinations, one whole kidney, or 1 ml of blood or urine, or suitable portions thereof, diluted to 1 ml with distilled water, were used. Microsomal heme oxygenase activity was determined on 20,000 g supernatant fractions of tissue homogenates (2, 3, 5) and expressed as mnumoles bilirubin formed per 10 mg protein in 1 min. For computation of total organ enzyme activity, the assumption was made that all microsomal heme oxygenase activity was recovered in the 20,000 g supernatant fraction of the homogenate (2) .
All experiments were carried out on groups of rats of similar age matched by weight. Hemoglobin was administered by a single injection into the tail vein after the animals had been lightly anesthetized with ether. The volume of fluid injected was usually about 1 ml and never exceeded 3 ml. Control animals received an intravenous injection of isotonic saline. In most experiments, 30 mg of hemoglobin per 100 g body weight was given; this dose exceeded by far the haptoglobin-binding capacity of the plasma (10) , regularly led to hemoglobinuria and generally resulted in maximal stimulation of renal heme oxygenase activity. In the dose-effect studies, 5-50 mg of hemoglobin was injected per 100 g body weight.
Cyclohexamide (Sigma Chemical Co., St. Louis, Mo.), puromycin (Nutritional Biochemical Corporation, Cleveland, Ohio), or actinomycin D (Sigma Chemical Co.), were given intraperitoneally either 1 hr before or 2 (actinomycin) or 4 hr (cyclohexamide) after the intravenous administration of 30 mg of hemoglobin per 100 g body weight; puromycin was inj ected hourly. Control animals received isotonic saline, given intraperitoneally at comparable times. The doses of these inhibitors used were similar to those employed in studies of 5-aminolevulinic acid synthetase in rat liver (21) , i.e. cyclohexamide, 1.8 mg, and actinomycin, 1.5 mg per kg; puromycin was given every hour in a dose of 100 mg per kg. To test the effectiveness of cyclohexamide in suppressing renal protein synthesis, 50 ACi of leucine-14C (New England Nuclear Corp, Boston, Mass.) was injected intravenously 1 hr after the intraperitoneal administration of cyclohexamide given at doses that ranged from 0.3 to 2.1 mg per kg body weight. 4 hr after the isotope administration, the kidneys were removed and the "Cactivity in the trichloroacetic acid-precipitable fraction was determined (12) . A dose of 1.8 mg per kg of cyclohexamide reduced leucine-"C incorporation into soluble kidney proteins by two-thirds.
In a series of experiments, the response of the kidneys to injected native hemoglobin was compared with that of BME-treated hemoglobin; the latter is poorly filtered by the glomeruli (11) because of its tetrameric form (22) . 40 rats received unlabeled hemoglobin or BME-hemoglobin intravenously at a dose of 15 mg per 100 g body weight, and the hemoglobin excreted in the urine during the ensuing 4 hr was measured. In 12 rats that had been given 30 mg per 100 g body weight of hemoglobin-59Fe or BMEhemoglobin-'9Fe, plasma radioactivity was measured at 1, 4, and 8 hr after the intravenous injection. From these values and the plasma volume estimated from the body weight (23), the total circulating radioactivity was calculated. Radioactivity excreted in the urine was compared with the excreted amount of hemoglobin, determined colorimetrically. Nine rats were depleted of their plasma haptoglobin (10, 11) by two preliminary intravenous injections of 10 mg native hemoglobin spaced 1 hr apart. 1 hr later, each animal received intravenously, 2 mg of BME-treated or 2
Heme Oxygenase in the Kidney 2043 mg of native hemoglobin, labeled with 'Fe. The total radioactivity in the kidneys and urine was determined after 4 hr. In a similar set of experiments, 24 rats of about 250 g body weight were injected with BME-treated hemoglobin-'Fe or with native hemoglobin-'mFe in a dose of 30 mg per 100 g body weight; this larger dose was selected to permit comparison of the results with those obtained in the other experimental series. In each group, the animals were sacrificed at intervals of i-1 hr up to 4 hr after receiving the isotope, and the radioactivity in both kidneys was determined. Under the assumption that most radioactivity present in the kidneys represented 'mFe of hemoglobin that had been filtered and subsequently reabsorbed, it was possible to calculate the fraction of the administered hemoglobin dose that had been retained in the kidneys during each interval. In these computations, no allowance was made for radioactivity in plasma trapped within the kidneys. Heme oxygenase activity in rat kidneys was determined 6 hr after a BILIRUBIN FORMED mA moles/10 mg protein/min single intravenous injection of BME-treated or of native hemoglobin in varying doses in order to determine the relationship between enzyme stimulation and the amount of blood pigment that was filtered and reabsorbed by the kidneys. In a group of 16 rats, heme oxygenase activity in the kidneys was compared with that in the liver 10 hr after a single intravenous injection of BME-treated or of native hemoglobin at a dose of 30 mg per 100 g body weight.
Experiments were performed in rats and rabbits to localize the anatomical site(s) of the stimulated enzyme in the kidneys. In rats the renal cortex (light tan) was easily distinguished from the renal medulla (pink), and cortical or medullary slices could be obtained by razor blade dissection under a dissecting microscope in a cold room at 4VC.
To the extent possible, all calyceal material was removed from the medullary slices. For each enzyme assay, slices of the kidneys of seven rats were pooled; three groups of seven animals were studied. All animals were sacrificed 10 hr after receiving 30 mg of hemoglobin per 100 g body weight.
Four rats were injected intravenously either with 30 mg hemoglobin per 100 g body weight or with an equivalent volume of isotonic saline. The animals were sacrificed 10 hr later, and the kidneys were removed and placed in 10% formaldehyde in isotonic saline. Thin sections of the kidneys were stained with hematoxylin and eosin for histological examination.
Three female New Zealand white rabbits of 3-3.5 kg body weight were injected in a marginal ear vein with rabbit hemoglobin (60 mg per ml saline) in a dose of 30-35 mg per 100 g body weight. The rabbits were sacrificed 10 hr later by intravenous injection of air, and the kidneys were removed immediately and placed in ice-cold Hank's solution. Slices of 1.5-2 mm thickness were cut through the center of the decapsulated kidneys with a razor blade. The slices were put in a Petri dish containing ice-cold Hank's solution and were oxygenated by a bubbling gas mixture of 95% oxygen and 5%o carbon dioxide. Clean proximal renal tubules were dissected from the cortex inward, using fine forceps and a stereoscopic microscope with 20 to 40 times magnification at room temperature. The 2044 Pimstone, Engel, Tenhunen, Seitz, Marver, and Schmid tubules were homogenized and microsomal heme oxygenase was assayed in a 20,000 g supernatant fraction, using a microassay method based on isotope dilution (24) .
RESULTS
Response of renal heme oxygenase to a single intravenous injection of hemoglobin. In confirmation of our previous report (5) , renal heme oxygenase activity in untreated or saline-injected rats was found to be very low (Table I) . Following a single intravenous injection of hemoglobin, enzyme activity in the kidneys remained low for an initial 2 hr, but then rose steeply to reach peak values between 6 and 16 hr (Fig. 1) . During the subsequent 30 hr, heme oxygenase activity gradually returned to preinjection levels ( Fig. 1) . At maximal stimulation, the total enzyme activity in the kidneys of hemoglobin-treated animals equaled or exceeded that in the spleen or the liver (Table I) .
The response of renal heme oxygenase activity 6 hr after a single intravenous injection of hemoglobin at different dose levels (Fig. 2) was characteristic of most dose-response curves and was linear to about 10 mg hemoglobin per 100 g body weight.
Since these time and dose-response curves were consistent with substrate-mediated enzyme induction, experiments were carried out with inhibitors of protein or ribonucleic acid (RNA) synthesis. Cyclohexamide, puromycin, or actinomycin D, given 1 hr before the injection of hemoglobin, greatly reduced or abolished the stimulatory effect of hemoglobin on renal heme oxygenase activity (Fig. 3) . Moreover, when cyclohexamide was given 4 hr after the hemoglobin injection, i.e. at a time when renal uptake of hemoglobin was virtually completed, the further stimulation of the enzyme was severely blunted (Fig. 4) . Similarly, actinomycin D given 2 hr following the hemoglobin administration, abolished after a short lag period, the stimulation of heme oxygenase activity in the kidneys (Fig. 5) with these metabolic inhibitors suggest that the hemoglobin-mediated stimulation of enzyme activity is dependent on the continued synthesis of renal RNA and protein. The slope of the declining enzyme activity after cyclohexamide (Fig. 4) approximates first order kinetics and suggests an apparent half-life for the renal enzyme of about 6 hr.
Relationship of renal heme oxygenase activity to glomerular filtration of hemoglobin. In order to further characterize the relationship between renal heme oxygenase activity and hemoglobin in the kidney, a series of experiments were carried out with BME-treated hemoglobin which is poorly filtered by the glomeruli (11 hemoglobin-'Fe or BME-treated hemoglobin-59Fe was injected in a dose of 30 mg per 100 g body weight, the radioactivity after 4 hr in the kidneys of the rats given BME-hemoglobin was about one-third less than in animals that had received native hemoglobin (Fig. 6) . In all instances, the rate of renal isotope uptake was rapid, and was nearly completed in 4 hr. These observations confirm the report by Bunn et al. (11) that complexing of hemoglobin with the sulfhydryl reagent BME greatly reduces its glomerular filtration, minimizes hemoglobinuria, and prolongs the hemoglobinemia.
When rats were injected with varying doses of BMEtreated hemoglobin, the stimulatory effect on renal heme oxygenase activity was significantly less at all dose levels than with native hemoglobin (Fig. 7) . By contrast, the pattern of enzyme stimulation in the liver was reversed, in that hepatic heme oxygenase activity was higher after injection of BME-treated hemoglobin than after native hemoglobin. Thus, in eight rats given 30 mg per 100 g body weight of BME-hemoglobin, enzyme activity (msmoles bilirubin/10 mg protein per min) after 10 hr in the liver was 0.44 (0.04 SE) and in the kidney 0.68 (0.11 SE). The respective values after administration of a comparable amount of native hemoglobin to eight rats were: liver 0.13 (0.007 SE), and kidneys 1.07 (0.06 SE). These results are significantly different at the P < 0.005 level (25) .
Anatomical localization of stimulated renal heme oxygenase activity. When renal cortex and medulla of hemoglobin-injected rats were assayed separately for heme oxygenase activity, most of the enzyme activity was found in the cortical tissue, with only traces present in the medulla (Fig. 8) . On histological examina- tion of hematoxylin and eosin-stained sections of kidneys obtained 10 hr after hemoglobin injection, the morphology of the nephron and the surrounding vessels appeared normal and there was no evidence of mononuclear cell infiltration. The kidneys of the three rabbits injected with hemoglobin exhibited heme oxygenase activity (Table III) comparable with that of stimulated rat kidney (Table I ). In the proximal tubules dissected from these kidneys (equivalent to 0.04-0.07 mg of protein), heme oxygenase activity of the microsomal fraction was slightly higher than in the comparable fraction obtained from the whole kidneys (Table III) . In tubular preparations obtained from control rabbits, no heme oxygenase activity was detectable.
DISCUSSION
The present results establish that the kidneys of rats and rabbits possess an enzymatic mechanism for the conversion of heme to bilirubin. This finding might have been anticipated, as Ostrow, Jandl, and Schmid (26) had shown that after infusion of 'Fe-, "C-labeled hemoglobin in rats, even when nearly half of the isotopic iron was retained in the kidneys, the heme-"C activity administered was almost quantitatively converted to bilirubin-"C excreted in the bile. Furthermore, the observations of Keene and Jandl (17) indicated that when plasma hemoglobin levels exceed the haptoglobin-binding capacity, the kidneys become a major site of hemoglobin uptake in the rat. More recently, Bunn and Jandl (12) demonstrataed by means of serial extractions, that hemoglobin, absorbed by the renal parenchyma, rapidly disappears from the kidneys leaving behind the iron moiety, which is mobilized more slowly. Finally, in chronic intravascular hemolysis, such as paroxysmal nocturnal hemoglobinuria, hemosiderin, presumably derived from iron-laden tubular cells (27) , frequently appears in the urine (28) . These observations suggested that in hemoglobinemia resulting in hemoglobinuria, the kidneys may play a major role in the catabolism of hemoglobin.
In tissues ordinarily concerned with the removal and degradation of senescent red cells, the heme of hemoglobin is converted to bile pigment by a microsomal heme oxygenase system (2-4). In vitro studies indicate that this enzyme can utilize as substrates only heme or easily dissociable heme-protein complexes (3). Thus, the enzymatic degradation of hemoglobin or of intracellular hemoproteins is probably governed first by factors that modify the hemoprotein to increase its dissociation constant. Heme oxygenase activity must then be coordinated with this process. An enzymatic apparatus exhibiting very similar properties and subcellular localization has now been demonstrated in the kidneys. However, under physiological conditions, renal heme oxygenase activity is very low but is increased manyfold following the filtration of plasma hemoglobin into the urine. This is reminiscent of the elevated heme oxygenase activity in the liver after splenectomy or experimental hemolysis (4, 5) and of the stimulation of the enzyme in macrophages that have ingested heme or he- (30) . The short biological halflife of microsomal heme oxygenase is surprising, but may serve to underscore the previously reported differences (3, 5) between the microsomal enzyme systems that catalyze the oxidation of drugs and of heme.
In the previous studies of the enzymatic conversion of heme to bilirubin (2-5), heme oxygenase activity was identified in tissues that were known to contain mesenchymal cells with phagocytic properties such as the spleen (2) (3) (4) (5) or liver (4, 5) or in isolated macrophages harvested from the peritoneal cavity or the lungs of rodents (9) . These findings were consistent with the postulate that hemoglobin catabolism is primarily a function of the reticuloendothelial system (31, 32) . It might have been expected, therefore, that heme oxygenase activity in the kidney also would be localized in phagocytic cells of mesenchymal origin located perhaps in the glomerular capillary loop or in the interstitial tissue of the renal medulla. However, the following findings point to the renal tubules as a major site of enzyme localization. In hemoglobinuric rats, heme oxygenase activity in the kidneys is confined almost entirely to the renal cortex (Fig. 8 ) which on histological examination showed no mononuclear cell infiltration. Functional studies with BME-treated hemoglobin also were in line with the concept that the enzyme activity is in the tubules rather than in the glomeruli. When hemoglobin was stabilized in its tetrameric form with BME, its glomerular filtration was minimized, less was taken up by the kidneys (Fig. 6) or lost in the urine, and consequently, the plasma level remained elevated for a longer time (Table II) . While administration of both BME-treated hemoglobin and native hemoglobin resulted in increased renal heme oxygenase activity (Fig. 7) , the stimulation in rats receiving the BME-treated hemoglobin was significantly less than in animals given the native hemoglobin. This is consistent with the postulate that heme oxygenase activity in the kidney is regulated by filtered hemoglobin that has been reabsorbed by the renal tubules, rather than by the plasma hemoglobin level. That BME-treated hemoglobin is a potent stimulator of heme oxygenase was demonstrated in the liver, where enzyme activity was considerably higher after the infusion of BMEtreated hemoglobin than after equivalent amounts of native hemoglobin, reflecting the delayed plasma clearance of the former.
Direct confirmation that heme oxygenase activity can be stimulated in proximal tubular cells was obtained by enzyme assay of tubular preparations isolated from the renal cortex of rabbits that had been given intravenous injections of hemoglobin. The measurement of heme oxygenase activity in the small amount of protein available with these preparations required the use of a newly developed microassay for the enzyme which is described by one of us (R. T.) in detail elsewhere. It was noted that the specific activity of heme oxygenase in isolated renal-tubular preparations was only slightly higher than that in the whole organ. This may not be surprising in view of the fact that clean dissection of renal tubules in amounts sufficient for enzyme assay required approximately 2 hr, during which time considerable enzyme activity may have been lost. This probably should be taken into account in comparing heme oxygenase activity in whole kidneys with that in isolated tubular preparations. Moreover, the possible lability of the enzyme system makes it difficult to exclude the presence of some degree of heme oxygenase activity in any tissue structure whose isolation requires prolonged exposure to room temperature. Since hemoproteins are ubiquitous and turn over continuously, the existence of enzymatic mechanisms capable of degrading heme may indeed by postulated for all cell types.
The demonstration of heme oxygenase activity in the proximal tubules of the kidney extends previous morphologic (12, 13) and functional (14, 15) observations which indicated that filtered hemoglobin in part may be reabsorbed and catabolized in the renal tubular apparatus. Although in hemoglobinuria this catabolic mechanism may be adaptively increased, the functional significance of this adaptive response for the preservation of the body's iron stores appears to be limited. In chronic mild hemoglobinemia, when the plasma haptoglobinbinding capacity is low or exhausted, the inducible heme oxygenase system in the renal tubules may serve to reduce hemoglobinuria thereby minimizing renal iron loss. It is apparent, however, that when the filtered load of hemoglobin is increased, this homeostatic mechanism is easily overwhelmed and thus rendered relatively ineffective. The role of the adaptive heme oxygenase system 2048 Pimstone, Engel, Tenhunen, Seitz, Marver, and Schmid of the kidney in the multifactorial pathogenesis of hemoglobinuric nephropathy (33) (34) (35) is unclear.
The presence of heme oxygenase activity in the tubular cells of the kidney, which are of epithelial origin, indicates that the enzymatic capacity to convert heme to bilirubin is not limited to phagocytic cells of mesenchymal origin. This is consistent with the previously presented inferential evidence that bilirubin may be formed in the hepatic parenchymal cells (5) . Thus, "early-labeled" bilirubin excreted in the bile (36), appears to reflect largely, turnover of heme and hemoproteins that are formed and broken down in the hepatocytes (37, 38) ; this turnover and consequently, the rate of bilirubin formation may be enhanced significantly by treatment with drugs such as phenobarbital (39) . It also is attractive to speculate that heme oxygenase may be present in the epithelial cells of the gut mucosa. In the intestines of blood sucking arthropods, the cells lining the mucosal surface have been observed to contain biliverdin (40) . In carnivorous and omnivorous mammals, hemoglobiniron that has reached the intestine may in part be absorbed and reutilized (41) (42) (43) (44) (45) ; the ferroprotoporphyrin appears to be cleaved after it has been absorbed by the intestinal mucosa but before the iron is released into the plasma (42) (43) (44) (45) . Although various mechanisms have been proposed to explain this phenomenon (43) (44) (45) , heme oxygenase in the epithelial cells of the intestinal mucosa would appear to be a likely possibility.
